Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2020-04-14 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
西南证券股份有限公司关于公司使用暂时闲置的部分募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Southwest Securities Co., Ltd. regarding Huabang Life Health Co., Ltd.'s use of temporarily idle raised funds for cash management. It references regulatory guidelines, fundraising details, usage of funds, investment types, risk control measures, and the sponsor's audit opinion. The document is not a full financial report like an Annual Report or Interim Report, nor is it a brief announcement or a certification letter. It is a specialized audit or verification report related to the use of raised funds, consistent with an Audit Report / Information filing. The document length is 3682 characters, which is relatively short but contains substantive content and detailed analysis, not just an announcement or certification. Therefore, it fits best under Audit Report / Information (AR). Q1 2020
2020-04-14 Chinese
2019年度独立董事述职报告（武文生）
Board/Management Information Classification · 95% confidence The document is titled '2019年度独立董事述职报告' which translates to '2019 Annual Independent Director's Work Report'. It details the independent director's duties, attendance at board meetings, opinions on various board matters, committee participation, investigations, and efforts to protect investor rights during the 2019 fiscal year. The content is a detailed report on the independent director's activities and opinions rather than a general annual report or financial statement. It is not a certification, call transcript, or announcement. The document length is 5720 characters, which is sufficient for a substantive report. This type of document fits best under the category of Board/Management Information (MANG), as it relates to management's reporting on governance and director activities.
2020-04-14 Chinese
募集资金使用管理办法（2020年4月）
Regulatory Filings Classification · 95% confidence The document is titled '募集资金使用管理办法' which translates to 'Management Measures for the Use of Raised Funds' and is dated April 2020. It details the rules, procedures, and oversight mechanisms for the management and use of funds raised by the company through securities issuance. The content includes regulatory references, internal controls, usage restrictions, reporting requirements, and supervisory responsibilities related to raised capital. It is a detailed policy or procedural document rather than a financial report, earnings release, or announcement. It does not contain financial statements, earnings data, or voting results. It is not a presentation or transcript. The document is a regulatory or compliance-related filing outlining internal governance and management practices for raised funds. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for filings that do not neatly fit into other categories but relate to compliance and regulatory matters.
2020-04-14 Chinese
2019年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2019 年年度报告摘要" which translates to "2019 Annual Report Summary". It contains detailed financial data, business descriptions, accounting policies, shareholder information, and operational analysis for the fiscal year 2019. The content includes comprehensive financial performance, business segments, and management discussion, which are typical components of an Annual Report. The document length is substantial (15,000 characters), indicating it is not a mere announcement or summary notice but a substantive report. Therefore, it fits the definition of an Annual Report (10-K). FY 2019
2020-04-14 Chinese
关于申请境外发行债券的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Huabang Life Health Co., Ltd. regarding the application for issuing overseas bonds. It details the board meeting resolution, the bond issuance plan, authorization matters, guarantee matters, and the independent directors' opinions. The document is relatively short (2759 characters) and serves as a formal announcement of the company's intention and authorization to issue bonds abroad. It does not contain actual financial statements or detailed financial results, nor is it a transcript or presentation. It is not a full report but an announcement of a financing activity. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2020-04-14 Chinese
关于同一控制下企业合并追溯调整财务数据的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from Huabang Life Health Co., Ltd. regarding retrospective adjustments to financial data due to a business combination under common control. It includes detailed financial data adjustments for prior periods, explanations of the accounting treatment according to Chinese accounting standards, and opinions from the board, independent directors, and supervisory board. The document is not a full annual or interim report but a specific announcement about retrospective financial data adjustments related to a business combination under common control. It contains substantive financial data and detailed explanations, which aligns with the characteristics of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or a simple announcement. The document length is 4361 characters, which is relatively short but contains detailed financial adjustments and audit opinions, indicating it is a standalone audit-related announcement rather than a mere publication announcement or regulatory filing. Therefore, the best fitting category is Audit Report / Information (AR). FY 2018
2020-04-14 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.